Glenmark gets USFDA nod to market generic drug for muscle pain

Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for Chlorzoxazone tablets USP, in strength of 375 mg and 750 mg, the drug maker said in a statement.

from Moneycontrol Business News https://ift.tt/36vDYgw